1-9 of 9
Stefan Stevanović
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Regulatory T Cells in an Endogenous Mouse Lymphoma Recognize Specific Antigen Peptides and Contribute to Immune Escape

Fatima Ahmetlić, Tanja Riedel, Nadine Hömberg, Vera Bauer, Nico Trautwein, Albert Geishauser, Tim Sparwasser, Stefan Stevanović, Martin Röcken, Ralph Mocikat
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (4): 600–608.
https://doi.org/10.1158/2326-6066.CIR-18-0419
Published: 01 April 2019
View article titled, Regulatory T Cells in an Endogenous Mouse Lymphoma Recognize Specific Antigen Peptides and Contribute to Immune Escape
Open the PDF for Regulatory T Cells in an Endogenous Mouse Lymphoma Recognize Specific Antigen Peptides and Contribute to Immune Escape in another window
Includes: Supplementary data
Journal Articles

Abstract B124: Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients

Armin Rabsteyn, Christina Kyzirakos, Christopher Schroeder, Marc Sturm, Christopher Mohr, Jakob Matthes, Magdalena Feldhahn, Nicolas Casadei, Martin Ebinger, Stefan Stevanovic, Peter Bauer, Oliver Kohlbacher, Cecile Gouttefangeas, Juergen Schaefer, Hans-Georg Rammensee, Rupert Handgretinger, Peter Lang
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): B124.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-B124
Published: 01 February 2019
View article titled, Abstract B124: Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients
Journal Articles

Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma

Alexander Ulges, Norbert Hilf, Wolfgang Wick, Michael Platten, Pierre-Yves Dietrich, Katrin Frenzel, Arie Admon, Sjoerd S.H. van der Burg, Andreas von Deimling, Per thor Straten, Cecile Gouttefangeas, Judith R. Kroep, Francisco Martínez-Ricarte, Hideo Okada, Christian H. Ottensmeier, Berta Ponsati, Hans S. Poulsen, Stefan Stevanovic, Ghazaleh Tabatabai, Hans-Georg Rammensee, Ugur Sahin, Dominik Maurer, Regina Mendrzyk
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): A020.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A020
Published: 01 February 2019
View article titled, Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma
Journal Articles

Abstract A112: Mapping the impact of proteasome inhibitor therapy on the antigenic landscape of multiple myeloma: Identifying robust targets for T cell immunotherapy

Daniel J. Kowalewski, Simon Walz, Linus Backert, Heiko Schuster, Oliver Kohlbacher, Lothar Kanz, Helmut R. Salih, Hans-Georg Rammensee, Stefan Stevanovic, Juliane S. Stickel
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A112.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A112
Published: 03 January 2016
View article titled, Abstract A112: Mapping the impact of proteasome inhibitor therapy on the antigenic landscape of multiple myeloma: Identifying robust targets for T cell immunotherapy
Journal Articles

Abstract B104: Characterization and specificity analysis of tumor infiltrating lymphocytes in ovarian carcinoma

Janet Kerstin Peper, Kevin Röhle, Heiko Schuster, Philipp Wagner, Hans-Georg Rammensee, Stefan Stevanovic
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): B104.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-B104
Published: 03 January 2016
View article titled, Abstract B104: Characterization and specificity analysis of tumor infiltrating lymphocytes in ovarian carcinoma
Journal Articles

Abstract A113: iVacALL: A personalized peptide-vaccination design platform for pediatric acute lymphoblastic leukemia patients based on patient-individual tumor-specific variants

Armin Rabsteyn, Christina Kyzirakos, Christopher Schröder, Marc Sturm, Christopher Mohr, Mathias Walzer, Ulrike Pflückhahn, Michael Walter, Magdalena Feldhahn, Karoline Laske, Michael Bonin, Martin Ebinger, Stefan Stevanovic, Peter Bauer, Oliver Kohlbacher, Cecile Gouttefangeas, Hans-Georg Rammensee, Rupert Handgretinger, Peter Lang
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A113.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A113
Published: 03 January 2016
View article titled, Abstract A113: iVacALL: A personalized peptide-vaccination design platform for pediatric acute lymphoblastic leukemia patients based on patient-individual tumor-specific variants
Journal Articles

Abstract B057: Optimizing the high throughput in vitro priming of tumor specific T cells

Lea Prokop, Stefanie Souczek, Janet Peper, Hans-Georg Rammensee, Stefan Stevanović
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): B057.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-B057
Published: 03 January 2016
View article titled, Abstract B057: Optimizing the high throughput in vitro priming of tumor specific T cells
Journal Articles

Spontaneous Peripheral T-cell Responses toward the Tumor-Associated Antigen Cyclin D1 in Patients with Clear Cell Renal Cell Carcinoma

Stefanie R. Dannenmann, Thomas Hermanns, Ali Bransi, Claudia Matter, Lotta von Boehmer, Stefan Stevanovic, Peter Schraml, Holger Moch, Alexander Knuth, Maries van den Broek
Journal: Cancer Immunology Research
Cancer Immunol Res (2013) 1 (5): 288–295.
https://doi.org/10.1158/2326-6066.CIR-13-0113
Published: 01 November 2013
View article titled, Spontaneous Peripheral T-cell Responses toward the Tumor-Associated Antigen Cyclin D1 in Patients with Clear Cell Renal Cell Carcinoma
Open the PDF for Spontaneous Peripheral T-cell Responses toward the Tumor-Associated Antigen Cyclin D1 in Patients with Clear Cell Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Alternative Variants of Human HYDIN Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity

Karoline Laske, Yuriy V. Shebzukhov, Ludger Grosse-Hovest, Dmitry V. Kuprash, Svetlana V. Khlgatian, Ekaterina P. Koroleva, Alexey Y. Sazykin, Dmitry N. Penkov, Pavel V. Belousov, Stefan Stevanović, Verona Vass, Steffen Walter, David Eisel, Barbara D. Schmid-Horch, Sergei A. Nedospasov, Hans-Georg Rammensee, Cécile Gouttefangeas
Journal: Cancer Immunology Research
Cancer Immunol Res (2013) 1 (3): 190–200.
https://doi.org/10.1158/2326-6066.CIR-13-0079
Published: 08 September 2013
View article titled, Alternative Variants of Human <em>HYDIN</em> Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity
Open the PDF for Alternative Variants of Human <em>HYDIN</em> Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity in another window
Includes: Supplementary data